Profile | GDS4284 / 208238_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1919.97 | 83 |
GSM687648 | Patient 402 control | 1730.33 | 82 |
GSM687653 | Patient 403 control | 3078.7 | 89 |
GSM687658 | Patient 404 control | 2236.59 | 85 |
GSM687663 | Patient 411 control | 2572.78 | 87 |
GSM687668 | Patient 422 control | 1906.19 | 83 |
GSM687673 | Patient 424 control | 2533.44 | 87 |
GSM687678 | Patient 425 control | 2709.86 | 87 |
GSM687683 | Patient 427 control | 3196.43 | 89 |
GSM687688 | Patient 428 control | 2096.92 | 85 |
GSM687695 | Patient 441 control | 2568.26 | 88 |
GSM687699 | Patient 443 control | 2824.23 | 88 |
GSM687704 | Patient 444 control | 2729.38 | 88 |
GSM687707 | Patient 448 control | 3005.74 | 89 |
GSM687712 | Patient 449 control | 1804.14 | 83 |
GSM687719 | Patient 450 control | 2781.33 | 88 |
GSM687724 | Patient 451 control | 2968.73 | 89 |
GSM687728 | Patient 452 control | 2442.74 | 86 |
GSM687646 | Patient 401 treated 24h | 2480.79 | 86 |
GSM687649 | Patient 402 treated 24h | 1434.6 | 79 |
GSM687665 | Patient 411 treated 24h | 2850.16 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 2793.66 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2133.01 | 84 |
GSM687670 | Patient 422 treated 24h | 2745.15 | 88 |
GSM687671 | Patient 422 treated 4 weeks | 2526.61 | 87 |
GSM687654 | Patient 403 treated 24h | 2211.62 | 85 |
GSM687675 | Patient 424 treated 24h | 2395.78 | 86 |
GSM687685 | Patient 427 treated 24h | 2250.52 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 2463.01 | 86 |
GSM687677 | Patient 424 treated 4 weeks | 2849.86 | 88 |
GSM687687 | Patient 427 treated 4 weeks | 2088.47 | 84 |
GSM687692 | Patient 428 treated 4h | 2249.73 | 85 |
GSM687716 | Patient 449 treated 4h | 2519.96 | 87 |
GSM687722 | Patient 450 treated 4h | 2528.91 | 87 |
GSM687680 | Patient 425 treated 24h | 2000.86 | 84 |
GSM687690 | Patient 428 treated 24h | 1658.43 | 81 |
GSM687700 | Patient 443 treated 24h | 3022.01 | 89 |
GSM687705 | Patient 444 treated 24h | 2632.42 | 87 |
GSM687714 | Patient 449 treated 24h | 1775.83 | 82 |
GSM687721 | Patient 450 treated 24h | 1754.63 | 83 |
GSM687682 | Patient 425 treated 4 weeks | 2111.16 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 2206.42 | 85 |
GSM687702 | Patient 443 treated 4 weeks | 3501.23 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 3680.6 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 1972.22 | 84 |
GSM687661 | Patient 404 treated 4h | 2426.29 | 86 |
GSM687710 | Patient 448 treated 4h | 2256.47 | 86 |
GSM687726 | Patient 451 treated 4h | 3258.46 | 90 |
GSM687730 | Patient 452 treated 4h | 7972.74 | 96 |
GSM687660 | Patient 404 treated 24h | 2203.75 | 86 |
GSM687697 | Patient 441 treated 24h | 2545.1 | 87 |
GSM687709 | Patient 448 treated 24h | 2853.09 | 88 |
GSM687725 | Patient 451 treated 24h | 2990.68 | 89 |
GSM687729 | Patient 452 treated 24h | 2523.16 | 88 |
GSM687727 | Patient 451 treated 4 weeks | 3720.38 | 91 |
GSM687731 | Patient 452 treated 4 weeks | 2246.36 | 85 |